Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lomitapide in Homozygous Familial Hypercholesterolemia
NCT00730236Phase 3Completed
- Sponsor
- Aegerion Pharmaceuticals
- Start
- Dec 2007
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of lomitapide in homozygous familial hypercholesterolemia (HoFH), sponsored by Aegerion Pharmaceuticals. Started Dec 2007; status: completed.
02
Drugs
lomitapide
03
Conditions
homozygous familial hypercholesterolemia (HoFH)
Beyond the preview
Go deeper on NCT00730236.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00730236.